← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2015Last known activity
Oct 1, 2025
Timeline
2000s
- Jun 1, 2007
CellSight Technologies, Inc.— Founded
Drugs by trial phase (8 distinct, 18 trials)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT07168785CollaboratorEarly Phase 1Oct 1, 2025
- NCT06107374Lead sponsorPhase 2Nov 1, 2023
- NCT06084806Lead sponsorPhase 2Oct 31, 2023
- NCT05096234CollaboratorPhase 2Sep 28, 2021
- NCT04260256Lead sponsorPhase 2Aug 31, 2021
- NCT04815096Lead sponsorEarly Phase 1Apr 15, 2021
- NCT04726215Lead sponsorPhase 2Apr 15, 2021
- NCT04726215Overall official - principal investigatorPhase 2Apr 15, 2021
- NCT04678440CollaboratorEarly Phase 1Mar 31, 2021
- NCT04524195CollaboratorPhase 1Feb 1, 2021
- NCT04401995CollaboratorPhase 2Jun 30, 2020
- NCT04186988CollaboratorEarly Phase 1Nov 5, 2019
- NCT04052412CollaboratorPhase 1Jul 16, 2019
- NCT03367962Lead sponsorPhase 1May 15, 2018
- NCT03311672CollaboratorPhase 2Nov 26, 2017
Details
- Founded
- San Francisco, CA, US Jun 1, 2007
- Last known activity
- Oct 1, 2025